Arialys Therapeutics
Small molecule therapeutics targeting neuroinflammation and psychiatric disorders
- Sector
- Biotech
- Headquarters
- LA JOLLA, CA
- Founded
- 2021
- Latest Form D
- $14.8M, Jul 2025
- Total capital
- $29.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $29.1M
- 2 Form D · last Jul 2025
- 16 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 11 pending · first 2025
- Rank in peer group#397 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$14.8M
- Private capital raisedForm D · SEC · 1st filing$14.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#397 · top 27%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Ashish Xavier, Ph.D.DirectorNamed in SEC Form D filings
- Brian Slingsby, M.D., Ph.D., M.P.H.DirectorNamed in SEC Form D filings
- Ed HurwitzDirectorNamed in SEC Form D filings
- Jay Lichter, Ph.D.DirectorNamed in SEC Form D filings
- Peter Flynn, Ph.D.Executive Officer, DirectorNamed in SEC Form D filings
- Tighe ReardonExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 13- GrantedAnti-human NR1 Antibody DerivativeUSPTOUS 12,649,786
- PendingMethods And Systems For Identifying Or Treating Central Nervous Systems DiseaseUSPTOApplication 19035338
- GrantedAnti-human NR1 Antibody DerivativeUSPTOUS 12,331,113
Show all 13 patent records
- Anti-human NR1 Antibody DerivativeJun 9, 2026 · US 12,649,786Granted
- Methods And Systems For Identifying Or Treating Central Nervous Systems DiseaseAug 21, 2025 · Application 19035338Pending
- Anti-human NR1 Antibody DerivativeJun 17, 2025 · US 12,331,113Granted
- Detection Of Autoantibodies Against NR1Application 63701162Pending
- Methods Of Treating Anti- Nmdar Antibody Related DisordersApplication 63673454Pending
- Detection Of Autoantibodies Against NR1Application PCTUS2024022024Pending
- Methods And Systems For Identifying Or Treating Central Nervous Systems DiseaseApplication PCTUS2023071138Pending
- Detection Of Autoantibodies Against NR1Application 63493217Pending
- Methods And Systems For Identifying Or Treating Central Nervous Systems DiseaseApplication 63369923Pending
- Detection Of Autoantibodies Against NR1Application PCTUS2025048528Pending
- Detection Of Autoantibodies Against NR1Application 19168281Pending
- Methods Of Treating Anti-nmdar Antibody Related DisordersApplication PCTUS2025038125Pending
- Detection Of Autoantibodies Against NR1Application 63729630Pending
Related companies, and why
- Profluent Bio Inc.Similar federal contract value in Biotech · null in contracts
- TenSixty Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Inversion Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Protillion Biosciences, lnc.Similar federal contract value in Biotech · null in contracts
- Myosana Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- Urica Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .